Unknown

Dataset Information

0

Dectin-1 Positive Dendritic Cells Expand after Infection with Leishmania major Parasites and Represent Promising Targets for Vaccine Development.


ABSTRACT: Resistant mouse strains mount a protective T cell-mediated immune response upon infection with Leishmania (L.) parasites. Healing correlates with a T helper (Th) cell-type 1 response characterized by a pronounced IFN-? production, while susceptibility is associated with an IL-4-dependent Th2-type response. It has been shown that dermal dendritic cells are crucial for inducing protective Th1-mediated immunity. Additionally, there is growing evidence that C-type lectin receptor (CLR)-mediated signaling is involved in directing adaptive immunity against pathogens. However, little is known about the function of the CLR Dectin-1 in modulating Th1- or Th2-type immune responses by DC subsets in leishmaniasis. We characterized the expression of Dectin-1 on CD11c+ DCs in peripheral blood, at the site of infection, and skin-draining lymph nodes of L. major-infected C57BL/6 and BALB/c mice and in peripheral blood of patients suffering from cutaneous leishmaniasis (CL). Both mouse strains responded with an expansion of Dectin-1+ DCs within the analyzed tissues. In accordance with the experimental model, Dectin-1+ DCs expanded as well in the peripheral blood of CL patients. To study the role of Dectin-1+ DCs in adaptive immunity against L. major, we analyzed the T cell stimulating potential of bone marrow-derived dendritic cells (BMDCs) in the presence of the Dectin-1 agonist Curdlan. These experiments revealed that Curdlan induces the maturation of BMDCs and the expansion of Leishmania-specific CD4+ T cells. Based on these findings, we evaluated the impact of Curdlan/Dectin-1 interactions in experimental leishmaniasis and were able to demonstrate that the presence of Curdlan at the site of infection modulates the course of disease in BALB/c mice: wild-type BALB/c mice treated intradermally with Curdlan developed a protective immune response against L. major whereas Dectin-1-/- BALB/c mice still developed the fatal course of disease after Curdlan treatment. Furthermore, the vaccination of BALB/c mice with a combination of soluble L. major antigens and Curdlan was able to provide a partial protection from severe leishmaniasis. These findings indicate that the ligation of Dectin-1 on DCs acts as an important checkpoint in adaptive immunity against L. major and should therefore be considered in future whole-organism vaccination strategies.

SUBMITTER: Zimara N 

PROVIDER: S-EPMC5834765 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dectin-1 Positive Dendritic Cells Expand after Infection with <i>Leishmania major</i> Parasites and Represent Promising Targets for Vaccine Development.

Zimara Nicole N   Chanyalew Menberework M   Aseffa Abraham A   van Zandbergen Ger G   Lepenies Bernd B   Schmid Maximilian M   Weiss Richard R   Rascle Anne A   Wege Anja Kathrin AK   Jantsch Jonathan J   Schatz Valentin V   Brown Gordon D GD   Ritter Uwe U  

Frontiers in immunology 20180226


Resistant mouse strains mount a protective T cell-mediated immune response upon infection with <i>Leishmania</i> (L.) parasites. Healing correlates with a T helper (Th) cell-type 1 response characterized by a pronounced IFN-γ production, while susceptibility is associated with an IL-4-dependent Th2-type response. It has been shown that dermal dendritic cells are crucial for inducing protective Th1-mediated immunity. Additionally, there is growing evidence that C-type lectin receptor (CLR)-mediat  ...[more]

Similar Datasets

| S-EPMC7459136 | biostudies-literature
2012-11-08 | GSE42088 | GEO
| S-EPMC1219736 | biostudies-other
2012-11-08 | E-GEOD-42088 | biostudies-arrayexpress
2008-05-22 | GSE10442 | GEO
2015-01-02 | GSE64610 | GEO
| S-EPMC2715056 | biostudies-literature
| S-EPMC2430024 | biostudies-literature
| PRJNA311056 | ENA
| PRJNA242762 | ENA